The F/m Emerald Life Sciences Innovation ETF (LFSC) top stock holdings include Travere Therapeutics, Spyre Therapeutics, and Cogent Biosciences. The top 25 LFSC holdings ordered by weight make up 89.31% of the total fund. LFSC is an equity fund in the sector category that invests in publicly traded companies, focused on health care strategies within the North America region. This page includes a complete LFSC stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.
Top 25 LFSC Holdings
LFSC Geographic Exposure
LFSC's largest geographic exposure is United States at 92.2%, followed by United Kingdom at 6.9%.
LFSC Currency Exposure
LFSC is exclusively exposed to USD.
LFSC Sector Exposure
LFSC's largest sector exposure is Health Care at 79.9%, followed by Consumer Discretionary at 6.1%.
LFSC Industry Exposure
LFSC's largest industry exposure is Biotechnology at 58.3%, followed by Health Care Equipment & Supplies at 14.3%.
Health Care Equipment & Supplies
Diversified Consumer Services
Health Care Providers & Services
LFSC Sub-Industry Exposure
LFSC's largest sub-industry exposure is Biotechnology at 55.7%, followed by Health Care Equipment at 14.3%.